FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071323 [Registered on: 25/07/2024] Trial Registered Prospectively
Last Modified On: 24/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Preventive
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate whether personalized dietary and physical activity advice based on CGMS data would be effective in preventing the occurrence of gestational diabetes mellitus in high risk women. 
Scientific Title of Study   Evaluating the utility of continuous glucose monitoring system for behavioral modification in high risk women enrolled in early pregnancy for the prevention of gestational diabetes mellitus a pilot Randomized Control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yashdeep Gupta 
Designation  Additional Professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Room No-3074, Teaching Block, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Ansari Nagar, New Delhi

South
DELHI
110029
India 
Phone  9999598468  
Fax    
Email  yash_deep_gupta@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aakansha 
Designation  Senior Resident  
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Room No-3074, Teaching Block, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Ansari Nagar, New Delhi

South
DELHI
110029
India 
Phone  9650746218  
Fax    
Email  aakansha.0701@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Yashdeep Gupta 
Designation  Additional Professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Room No-3074, Teaching Block, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Ansari Nagar, New Delhi

South
DELHI
110029
India 
Phone  9999598468  
Fax    
Email  yash_deep_gupta@yahoo.co.in  
 
Source of Monetary or Material Support  
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi-110029, India 
 
Primary Sponsor  
Name  Dr Yashdeep Gupta 
Address  Room No-3074, Teaching Block, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi-110029, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yashdeep Gupta  All India Institute of Medical Sciences  C-wing, New Rajkumari OPD, Department of Endocrinology and Metabolism, New Delhi-110029
South
DELHI 
9999598468

yash_deep_gupta@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee, All India Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  High-risk women in early pregnancy with period of gestation less than 14 weeks 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Continuous Glucose Monitoring System  Women allocated to intervention arm will undergo 2 weeks of continuous glucose monitoring and will be asked to record (take photos) of all that they take in diet and record the timing and duration of dedicated physical activity. The impact of diet and physical activity on glycaemia will be understood through CGMS which records 96 glucose values per day and provides response to individual meal. Standardized CGM metrics as per the 2019 International Consensus on CGM metrics will be noted. After detailed interpretation of diet, physical activity, and CGMS data, individualized diet and physical activity advice will be given. CGMS insertion and tailored dietary and physical activity advice will also be repeated between 24-28 weeks gestation. 
Comparator Agent  Usual care  Women in the control arm will be given a diet chart prepared by a dietician and given physical activity advice as part of usual care. 
 
Inclusion Criteria  
Age From  18.00 Month(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Women 18 years or older in early pregnancy with period of gestation less than 14 weeks. The participant should have one or more risk factors for gestational diabetes mellitus. The patient should have a BMI more than equal to 25 kilogram per meter square or BMI more than or equal to 23 Kilogram per meter square with hypertension or history of PCOS or previous history of gestational diabetes mellitus or family history of diabetes in first degree relative or age more than 35 years. The patient should have a singleton pregnancy confirmed by ultrasonography and should be enrolled either in the Department of Endocrinology and Metabolism or Department of Obstetrics and Gynaecology AIIMS Delhi. The participant should also be willing to comply with the study protocol. 
 
ExclusionCriteria 
Details  Women with Type 1 diabetes mellitus secondary diabetes or overt and pre-existing diabetes or gestational diabetes defined as per WHO 2019 criteria. The participant should not have any systemic illness with major organ dysfunction and should not be on steroids. Women with eczema or with a skin condition which precludes using a continuous glucose monitoring device will also be excluded. Women who do not have a smartphone as diet pictures have to be shared on real time basis.
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Difference in the incidence of gestational diabetes mellitus between the intervention and control groups  At 28 weeks period of gestation 
 
Secondary Outcome  
Outcome  TimePoints 
Difference in between the two groups in appropriate gestational weight gain both total and per week.  At baseline, between 24 to 28 weeks period of gestation, between 34-38 weeks period of gestation and at delivery. 
Difference in composite pregnancy outcome which will be a composite of neonate born large for gestational age
gestational hypertension or pre-eclampsia, small for gestational age, Apgar score less than 7, hyperbilirubinemia, respiratory distress syndrome, clinically significant neonatal hypoglycemia, preterm birth, perinatal mortality, NICU admission for more than 24 hours
 
At delivery 
Percentage of women who wore CGMS for the entire duration of two weeks  At baseline and between 24 to 28 weeks period of gestation 
Percentage of women who shared the data of their diet for at least 70% of their meals  At baseline and between 24 to 28 weeks period of gestation 
Percentage of women who scanned periodically and provided more than 70% of the CGMS data  At baseline and between 24 to 28 weeks period of gestation 
Percentage of women adherent to all six assessment visits.  At delivery. 
Participant satisfaction with full intervention process  At delivery 
Perceived benefit of tailored behavioral modification advice by the participant  At delivery 
Participant satisfaction with the use of CGMS  At baseline and between 24-28 weeks 
Likely recommendation for use in other pregnant women by the participant  At delivery 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In this study we wish to evaluate the utility of tailored behavioral modification based on information provided by a continuous glucose monitoring device compared to usual care in which participants will be given a diet chart and advised physical activity. We wish to see the difference between the incidence of gestational diabetes mellitus in between these two groups as well as observe the differences between various maternal and neonatal outcomes. 
Close